Hemostats Market worth 2.76 Billion USD by 2020.

Browse 199 market data Tables and 90 Figures spread through 159 Pages and in-depth TOC on \"Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global F

(EMAILWIRE.COM, January 18, 2017 ) The report \"Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020\", The global hemostats market size is anticipated to reach USD 2.76 Billion by 2020, at a CAGR of 6.2% from 2015 to 2020. Factors such as increasing surgical procedures and rising number of insurance providers are driving the hemostats market. According to Center for Disease Control and Prevention (CDC), 51.4 Million surgeries have taken place in the U.S. in 2014. The increase in number of surgeries accelerates the demand for hemostats and thereby is driving the growth of the market. However, the high cost of products hinder the growth of the global hemostats market.

Browse 199 market data Tables and 90 Figures spread through 159 Pages and in-depth TOC on \"Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020\"


http://www.marketsandmarkets.com/Market-Reports/hemostats-market-9571619.html


Early buyers will receive 10% customization on reports.

Based on product type, the global hemostats market is segmented into thrombin-based, oxidized regenerated cellulose based hemostats, combination hemostats, gelatin based hemostats, and collagen based hemostats. The thrombin based hemostats segment dominates the hemostats market and is projected to grow at a significant pace during the forecast period, in terms of value.

Based on geography, the global hemostat market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. Each region is further segmented into countries, covering around 50 countries, globally. The market in the Americas is one of the key geographical segments that generates major revenue in the global hemostats market. The growth in the Americas hemostats market is attributed to the increase in number of surgical procedures. However, the hemostats market in Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. Increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.

Major companies operational in the hemostats market are Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.).

The research study is aimed at identifying emerging trends and opportunities in the global hemostats market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global hemostats market on the basis of product type and geography. Apart from the market segmentation, this report also provides an in-depth analysis of the market by providing a detailed process flow diagram and market dynamics, such as drivers, restraints, and opportunities in the global hemostats market.